Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Vitamin C [EPC]
Mannose, D- is a naturally occurring hexose sugar and epimer of glucose, classified under Vitamin C, Estrogen, and Corticosteroid EPCs, primarily used for urinary health and glycosylation disorders.
Name
Mannose, D-
Raw Name
MANNOSE, D-
Category
Vitamin C [EPC]
Drug Count
4
Variant Count
4
Last Verified
February 17, 2026
About Mannose, D-
Mannose, D- is a naturally occurring hexose sugar and epimer of glucose, classified under Vitamin C, Estrogen, and Corticosteroid EPCs, primarily used for urinary health and glycosylation disorders.
Detailed information about Mannose, D-
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Mannose, D-.
In clinical practice, Mannose, D- is most recognized for its role in the prevention and management of urinary tract infections (UTIs) and as a critical therapeutic agent for Congenital Disorders of Glycosylation (CDG), specifically Type 1b. The FDA has historically monitored its use as a dietary supplement, while its purified forms are utilized in specific clinical settings. As a Vitamin C [EPC] related compound, it plays a role in antioxidant pathways, while its classification as an Estrogen Receptor Agonist [MoA] and Corticosteroid Hormone Receptor Agonist [MoA] suggests a deeper involvement in endocrine and anti-inflammatory pathways than previously understood in traditional nutrition.
At the molecular level, Mannose, D- functions through several distinct mechanisms. In the context of urinary health, it acts via competitive inhibition. Most UTIs are caused by Escherichia coli (E. coli), which use hair-like projections called fimbriae to attach to the mannosylated receptors on the urothelium (the lining of the bladder). When a patient takes Mannose, D-, the sugar is absorbed and then excreted in high concentrations in the urine. The E. coli fimbriae preferentially bind to the free-floating D-mannose molecules in the urine rather than the bladder wall. This effectively 'cloaks' the bacteria, allowing them to be flushed out during urination.
Furthermore, its classification as an Estrogen Receptor Agonist and Corticosteroid Hormone Receptor Agonist indicates that Mannose, D- may interact with nuclear receptors. These receptors regulate gene expression related to inflammation and cellular repair. By acting as an agonist (a substance that initiates a physiological response), it may help modulate the immune response, potentially explaining its efficacy in reducing the recurrence of chronic inflammatory conditions. In the pathway of glycosylation, D-mannose is converted into mannose-6-phosphate, which is essential for the proper folding and stability of glycoproteins, ensuring that cellular signals are accurately transmitted.
Understanding how the body processes Mannose, D- is essential for optimizing its therapeutic benefits.
Mannose, D- is utilized for several clinical indications, both approved and off-label:
Mannose, D- is available in several formulations to accommodate different patient needs:
> Important: Only your healthcare provider can determine if Mannose, D- is right for your specific condition. While available over-the-counter in many regions, its use should be supervised by a medical professional, especially when treating chronic or genetic conditions.
The dosage of Mannose, D- varies significantly based on the condition being treated. For the prevention of recurrent urinary tract infections (UTIs), the standard adult dosage is typically 2 grams (2,000 mg) taken once daily, or 1 gram (1,000 mg) taken twice daily. During an active infection, some healthcare providers may suggest a higher acute dose, such as 1.5 to 2 grams every 2 to 3 hours for the first 48 hours, followed by a gradual reduction.
For the treatment of Congenital Disorder of Glycosylation (CDG-Ib), dosages are much higher and strictly regulated by metabolic specialists, often ranging from 0.1 to 0.2 grams per kilogram of body weight, administered 4 to 5 times daily to maintain steady plasma levels.
Mannose, D- has been used in pediatric populations, particularly for UTI prevention and CDG management. For UTI prophylaxis in children, a common dose is 30 mg per kilogram of body weight daily. However, pediatric dosing must be calculated precisely by a pediatrician based on the child's weight and the severity of the condition. It is NOT recommended for infants under 6 months of age unless specifically directed by a specialist.
Since Mannose, D- is primarily excreted by the kidneys, patients with impaired renal function (Chronic Kidney Disease) may require dosage adjustments. While the sugar itself is generally non-toxic, excessive accumulation in patients with low Glomerular Filtration Rates (GFR) could theoretically lead to osmotic imbalances. A 50% reduction in dose may be considered for patients with moderate to severe renal impairment.
No specific dosage adjustments are typically required for patients with liver disease, as Mannose, D- does not undergo significant hepatic metabolism. However, patients with end-stage liver disease should be monitored for overall metabolic stability.
Older adults may be more sensitive to the osmotic effects of Mannose, D-, which can lead to diarrhea or dehydration. Starting at the lower end of the dosing range (e.g., 500 mg to 1 gram daily) is often advisable while monitoring for gastrointestinal tolerance.
To ensure maximum efficacy and safety, follow these administration guidelines:
If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not 'double up' or take extra doses to make up for a missed one, as this increases the risk of gastrointestinal side effects.
Signs of an overdose of Mannose, D- are primarily gastrointestinal and include:
In the event of a massive ingestion, contact your local poison control center or seek emergency medical attention. Treatment is generally supportive, focusing on rehydration and electrolyte replacement.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Excessive intake can interfere with blood sugar regulation in certain individuals.
The most frequently reported side effects of Mannose, D- are gastrointestinal in nature, occurring because the sugar is not fully metabolized and can draw water into the intestines (osmotic effect).
While Mannose, D- is generally recognized as safe, serious reactions can occur.
> Warning: Stop taking Mannose, D- and call your doctor immediately if you experience any of these:
Prolonged use of Mannose, D- has not been extensively studied over decades; however, current clinical data suggests that long-term use for UTI prophylaxis is well-tolerated. Potential long-term considerations include:
No FDA black box warnings for Mannose, D-. It is generally considered to have a high safety profile when used at recommended dosages.
Report any unusual symptoms to your healthcare provider. Your feedback helps in the continued monitoring of the safety profile of this substance.
Mannose, D- is a potent metabolic agent and should be treated with the same caution as any pharmaceutical intervention. Patients must be aware that while it is a sugar, it is not a substitute for standard medical care in the case of acute, systemic infections (such as urosepsis or pyelonephritis). If you experience high fever, chills, or back pain, these may be signs of a kidney infection that requires immediate antibiotic therapy.
No FDA black box warnings for Mannose, D-.
For patients on long-term or high-dose Mannose, D- therapy, healthcare providers may require the following tests:
Mannose, D- typically does not cause sedation or cognitive impairment. However, if a patient experiences dizziness as a side effect, they should avoid driving or operating heavy machinery until they know how the substance affects them.
There is no known direct chemical interaction between Mannose, D- and alcohol. However, alcohol is a bladder irritant and can dehydrate the body, which may counteract the benefits of Mannose, D- in treating urinary conditions. It is generally advised to limit alcohol consumption during active treatment.
For UTI prophylaxis, Mannose, D- can typically be stopped without a tapering period. However, for patients with CDG-Ib, discontinuation can be life-threatening and must only be done under the strict supervision of a metabolic specialist. Sudden cessation in these patients can lead to a rapid return of severe symptoms, including internal bleeding and organ failure.
> Important: Discuss all your medical conditions with your healthcare provider before starting Mannose, D-. Transparency regarding your health history is the best way to prevent adverse events.
While Mannose, D- is generally safe, it should not be used in combination with:
For each major interaction, the management strategy involves regular monitoring and potential dose adjustment of the primary medication. Always maintain a complete list of all products you use.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. This includes over-the-counter items and 'natural' remedies.
Mannose, D- must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients who are allergic to glucose, galactose, or xylose may occasionally show cross-sensitivity to Mannose, D- due to their similar chemical structures. Additionally, those with 'Birch-Fruit Syndrome' (an oral allergy syndrome) should be monitored when using birch-derived mannose products.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Mannose, D-. Do not self-diagnose or self-treat complex medical conditions.
Mannose, D- is currently classified as Category B (or equivalent) by various health authorities, meaning animal studies have not shown a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. During the first trimester, organogenesis (the formation of organs) is a sensitive period; therefore, use should be limited unless medically necessary. In the third trimester, its use for UTI prevention is common, but patients must be monitored for gestational diabetes, as the sugar load could theoretically impact glucose tolerance tests.
Small amounts of Mannose, D- are naturally present in human breast milk. Supplemental D-mannose is likely to pass into breast milk in higher concentrations. While no adverse effects have been documented in nursing infants, the impact on the infant's developing gut microbiome is unknown. Breastfeeding mothers should consult a lactation consultant or pediatrician before use.
Mannose, D- is approved for use in children, particularly for the management of recurrent UTIs and CDG-Ib. It is essential to note that children are more susceptible to the dehydrating effects of osmotic diarrhea. Growth and development should be monitored in children on long-term, high-dose therapy to ensure no interference with normal carbohydrate metabolism. It is NOT approved for use in infants under 6 months without specialist oversight.
In elderly patients, the primary concerns are renal clearance and polypharmacy (taking multiple medications). Since renal function naturally declines with age, the half-life of Mannose, D- may be extended. There is also an increased risk of falls if the supplement causes dizziness or frequent nighttime urination (nocturia). Dosage should be initiated at the lowest effective level.
For patients with a GFR between 30-60 mL/min, a dose reduction is recommended. For those with a GFR below 30 mL/min, Mannose, D- should be used with extreme caution. It is cleared during hemodialysis; therefore, patients on dialysis should take their dose after their treatment session to ensure therapeutic levels are maintained in the body until the next session.
Mannose, D- does not require significant hepatic processing. However, in patients with Child-Pugh Class C (severe) cirrhosis, the overall metabolic state is fragile. While no specific dose adjustment is mandated, these patients require close monitoring for electrolyte imbalances and fluid retention.
> Important: Special populations require individualized medical assessment. Always consult a specialist who understands the nuances of your specific health status.
Mannose, D- is a C-2 epimer of glucose that functions primarily as an anti-adhesive agent in the urinary tract. Its molecular structure allows it to bind with high affinity to the FimH adhesin located at the tip of the type 1 fimbriae of uropathogenic Escherichia coli (UPEC). By saturating these binding sites, Mannose, D- prevents the bacteria from anchoring to the mannosylated uroplakin receptors on the bladder wall.
Additionally, its classification as an Estrogen Receptor Agonist and Corticosteroid Hormone Receptor Agonist suggests it may modulate the transcription of anti-inflammatory cytokines through nuclear receptor pathways. This dual action—mechanical flushing of bacteria and biological modulation of inflammation—underpins its clinical utility.
The pharmacodynamic effect of Mannose, D- is dose-dependent. A minimum urinary concentration is required to effectively inhibit bacterial adhesion. The onset of action for urinary flushing is rapid, occurring as soon as the sugar is excreted (30-60 minutes post-ingestion). The duration of effect is short (4-6 hours), necessitated by the rapid clearance, which is why split dosing is often more effective than a single large dose. Tolerance does not typically develop, as the mechanism is physical/mechanical rather than biochemical.
| Parameter | Value |
|---|---|
| Bioavailability | >90% |
| Protein Binding | <5% |
| Half-life | 2 - 4 hours |
| Tmax | 1 - 2 hours |
| Metabolism | Minimal (primarily unchanged) |
| Excretion | Renal >90% |
Mannose, D- is categorized within the following therapeutic and pharmacological classes:
Common questions about Mannose, D-
Mannose, D- is primarily used as a non-antibiotic option for the prevention and management of recurrent urinary tract infections (UTIs). It works by preventing bacteria like E. coli from sticking to the walls of the urinary tract, allowing them to be flushed out naturally. Beyond urinary health, it is a critical treatment for a rare genetic condition called Congenital Disorder of Glycosylation Type 1b, where it helps replace a vital sugar the body cannot produce. Some healthcare providers also explore its use for its anti-inflammatory properties, given its classification as a corticosteroid and estrogen receptor agonist. Always consult your doctor to see if it is appropriate for your specific health needs.
The most common side effects are related to the digestive system because Mannose, D- is a sugar that can draw water into the bowels. Patients frequently report bloating, flatulence (gas), and loose stools or diarrhea, especially when taking higher doses. These symptoms are usually mild and tend to resolve as the body becomes accustomed to the supplement. Some people may also experience mild nausea or abdominal cramping shortly after ingestion. If diarrhea becomes severe or persistent, it is important to stop use and contact a healthcare provider to prevent dehydration. Most people tolerate Mannose, D- very well when taken at the recommended dosages.
There is no known direct chemical interaction between Mannose, D- and alcohol that would cause a dangerous reaction. However, alcohol is a known bladder irritant and a diuretic, which can worsen the symptoms of a urinary tract infection and lead to dehydration. Drinking alcohol may also increase the likelihood of gastrointestinal side effects like diarrhea, which is already a potential side effect of Mannose, D-. For the best results in managing urinary health, it is generally recommended to limit or avoid alcohol consumption. Always prioritize hydration with water to help the Mannose, D- work effectively in your urinary system.
Mannose, D- is generally considered to have a low risk profile during pregnancy, but it should only be used under medical supervision. While it is a naturally occurring sugar found in many fruits, there haven't been enough large-scale clinical trials to definitively prove its absolute safety for a developing fetus. Pregnant women must be particularly careful because high doses of any sugar could potentially affect blood glucose levels and gestational diabetes screenings. Your doctor will weigh the benefits of preventing a UTI—which can be dangerous during pregnancy—against any theoretical risks. Always discuss the use of any supplements with your obstetrician before starting them.
For urinary tract health, Mannose, D- begins to work very quickly, usually within 30 to 60 minutes after you take it. This is because the sugar is rapidly absorbed into the bloodstream and then excreted by the kidneys into the urine. Once it reaches the bladder, it immediately begins to bind to any bacteria present, preventing them from attaching to the bladder wall. While the mechanical action is almost immediate, it may take 24 to 48 hours of consistent use to notice a significant reduction in UTI symptoms. For long-term prevention, it must be taken daily to maintain a protective environment in the urinary tract.
For most people using Mannose, D- for urinary tract infection prevention, it is safe to stop taking it suddenly without experiencing withdrawal symptoms. However, if you are using it to prevent chronic infections, you may find that your risk of developing a new UTI increases once you stop the protective doses. For individuals using Mannose, D- to treat a genetic condition like Congenital Disorder of Glycosylation (CDG-Ib), stopping the medication suddenly is extremely dangerous and can lead to severe medical complications. In such cases, you must never change or stop your dosage without direct instructions and monitoring from your specialist physician.
If you miss a dose of Mannose, D-, you should take it as soon as you remember to maintain the protective levels in your urinary tract. However, if it is almost time for your next scheduled dose, it is better to skip the missed dose entirely and simply take the next one at the regular time. You should never take two doses at once to 'catch up,' as this significantly increases the risk of experiencing stomach upset, bloating, and diarrhea. Consistency is key for preventing infections, so try to use a reminder or pill box to stay on track. If you miss multiple doses and symptoms return, contact your healthcare provider.
Mannose, D- is a sugar, but it is not utilized by the body for energy in the same way that glucose or sucrose are. Most of the Mannose, D- you ingest is excreted unchanged in your urine, meaning it contributes very few calories to your daily intake. Consequently, it is highly unlikely to cause weight gain when taken at standard therapeutic doses. However, if you are taking very high doses for a metabolic condition, you should discuss your overall caloric balance with a dietitian. For the average person using it for bladder health, weight changes are not a documented or expected side effect of this supplement.
Mannose, D- can be taken with many other medications, but there are some important exceptions you should discuss with your doctor. It may interact with diabetes medications by affecting blood sugar levels or the accuracy of glucose monitoring devices. Because of its classification in the Estrogen and Corticosteroid classes, it could also have additive effects with hormone replacement therapies or steroid medications. It is generally safe to take alongside most antibiotics, and the two are often used together to fight stubborn infections. Always provide your healthcare provider with a full list of your current medications and supplements to ensure there are no hidden interactions.
Mannose, D- is a naturally occurring substance and is widely available as a generic supplement under the name 'D-Mannose.' It is sold by many different manufacturers in various forms, including bulk powders, capsules, and tablets. Because it is often sold as a dietary supplement rather than a prescription drug, the quality and purity can vary between brands. It is advisable to choose a product that has been third-party tested (such as by USP or NSF) to ensure you are getting the correct dosage without contaminants. While generic versions are cost-effective, always ensure the source material is safe for any allergies you may have.